BAY Trial: Randomised Controlled Trial

  • Research type

    Research Study

  • Full title

    Behavioural Activation for Young people with depression in specialist child and adolescent mental health services

  • IRAS ID

    319136

  • Contact name

    Bernadka Dubicka

  • Contact email

    bernadka.dubicka@york.ac.uk

  • Sponsor organisation

    Greater Manchester Mental Health Trust

  • ISRCTN Number

    ISRCTN12315118

  • Duration of Study in the UK

    2 years, 11 months, 2 days

  • Research summary

    Rates of emotional disorders in young people (YP) have been increasing and the covid-
    19 pandemic is disproportionately affecting the mental health of YP. From 2017 to 2022, rates in young people aged 17 to 19 rose from 1 in 10 (10.1%) to 1 in 4 (25.7%)

    Even before the pandemic, only 25% of children and YP with mental health disorders accessed help; those that do often have long waits for specialist therapy after assessment.The government Green Paper offers help in schools for YP with mild to moderate problems. However, YP with more severe depression and high risk are still referred to specialist child and adolescent mental health services (CAMHS) where there is a significant shortage of skilled staff and insufficient therapy skills.

    Delivery modes have changed since Covid-19 with remote working and blended therapy. To meet these changes we developed a behavioural activation (BA) intervention with brief training to clinicians without specialist therapy skills to deliver blended BA.

    The BAY study aims to examine the effectiveness, cost-effectiveness and acceptability of BA (‘Be-Active’) using blended delivery, when compared to Treatment as usual + psycho education (PE) in depressed adolescents referred to specialist CAMHS.

    Recruitment will take place in NHS specialist CAMHS across 5 trusts in England.528 young people aged 11-17 with low mood on initial assessment will be randomised and outcome data collected at baseline, 12 weeks, 6 months & 12 months with an optional qualitative interview at the end of treatment.

    If BA is effective and cost-effective, it would increase access to a treatment that
    can be delivered at scale in specialist CAMHS; this study would also give us information on the acceptability of different modes of delivery. BA could potentially free up more experienced staff, reduce waiting times for more specialist interventions, and provide an additional therapeutic response to the future mental health impacts of this pandemic.

  • REC name

    East of England - Cambridge South Research Ethics Committee

  • REC reference

    23/EE/0073

  • Date of REC Opinion

    16 Jun 2023

  • REC opinion

    Further Information Favourable Opinion